Cargando…
Intestinal absorption, organ distribution, and urinary excretion of the rare sugar D-psicose
BACKGROUND: The purpose of this study was to evaluate intestinal absorption, organ distribution, and urinary elimination of the rare sugar D-psicose, a 3-carbon stereoisomer of D-fructose that is currently being investigated and which has been found to be strongly effective against hyperglycemia and...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207542/ https://www.ncbi.nlm.nih.gov/pubmed/25378908 http://dx.doi.org/10.2147/DDDT.S60247 |
_version_ | 1782340986226081792 |
---|---|
author | Tsukamoto, Ikuko Hossain, Akram Yamaguchi, Fuminori Hirata, Yuko Dong, Youyi Kamitori, Kazuyo Sui, Li Nonaka, Machiko Ueno, Masaki Nishimoto, Kazuyuki Suda, Hirofumi Morimoto, Kenji Shimonishi, Tsuyoshi Saito, Madoka Song, Tao Konishi, Ryoji Tokuda, Masaaki |
author_facet | Tsukamoto, Ikuko Hossain, Akram Yamaguchi, Fuminori Hirata, Yuko Dong, Youyi Kamitori, Kazuyo Sui, Li Nonaka, Machiko Ueno, Masaki Nishimoto, Kazuyuki Suda, Hirofumi Morimoto, Kenji Shimonishi, Tsuyoshi Saito, Madoka Song, Tao Konishi, Ryoji Tokuda, Masaaki |
author_sort | Tsukamoto, Ikuko |
collection | PubMed |
description | BACKGROUND: The purpose of this study was to evaluate intestinal absorption, organ distribution, and urinary elimination of the rare sugar D-psicose, a 3-carbon stereoisomer of D-fructose that is currently being investigated and which has been found to be strongly effective against hyperglycemia and hyperlipidemia. METHODS: This study was performed using radioactive D-psicose, which was synthesized enzymatically from radioactive D-allose. Concentrations in whole blood, urine, and organs were measured at different time points until 2 hours after both oral and intravenous administrations and 7 days after a single oral administration (100 mg/kg body weight) to Wistar rats. Autoradiography was also performed by injecting 100 mg/kg body weight of (14)C-labeled D-psicose or glucose intravenously to C3H mice. RESULTS: Following oral administration, D-psicose easily moved to blood. The maximum blood concentration (48.5±15.6 μg/g) was observed at 1 hour. Excretion to urine was 20% within 1 hour and 33% within 2 hours. Accumulation to organs was detected only in the liver. Following intravenous administration, blood concentration was decreased with the half-life=57 minutes, and the excretion to urine was up to almost 50% within 1 hour. Similarly to the results obtained with oral administration, accumulation to organs was detected only in the liver. Seven days after the single-dose oral administration, the remaining amounts in the whole body were less than 1%. Autoradiography of mice showed results similar to those in rats. High signals of (14)C-labeled D-psicose were observed in liver, kidney, and bladder. Interestingly, no accumulation of D-psicose was observed in the brain. CONCLUSION: D-psicose was absorbed well after oral administration and eliminated rapidly after both oral and intravenous administrations, with short duration of action. The study provides valuable pharmacokinetic data for further drug development of D-psicose. Because the findings were mainly based on animal study, it is necessary to implement human trials to study the metabolism pathway, which would give an important guide for human intake and food application of D-psicose. |
format | Online Article Text |
id | pubmed-4207542 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-42075422014-11-06 Intestinal absorption, organ distribution, and urinary excretion of the rare sugar D-psicose Tsukamoto, Ikuko Hossain, Akram Yamaguchi, Fuminori Hirata, Yuko Dong, Youyi Kamitori, Kazuyo Sui, Li Nonaka, Machiko Ueno, Masaki Nishimoto, Kazuyuki Suda, Hirofumi Morimoto, Kenji Shimonishi, Tsuyoshi Saito, Madoka Song, Tao Konishi, Ryoji Tokuda, Masaaki Drug Des Devel Ther Original Research BACKGROUND: The purpose of this study was to evaluate intestinal absorption, organ distribution, and urinary elimination of the rare sugar D-psicose, a 3-carbon stereoisomer of D-fructose that is currently being investigated and which has been found to be strongly effective against hyperglycemia and hyperlipidemia. METHODS: This study was performed using radioactive D-psicose, which was synthesized enzymatically from radioactive D-allose. Concentrations in whole blood, urine, and organs were measured at different time points until 2 hours after both oral and intravenous administrations and 7 days after a single oral administration (100 mg/kg body weight) to Wistar rats. Autoradiography was also performed by injecting 100 mg/kg body weight of (14)C-labeled D-psicose or glucose intravenously to C3H mice. RESULTS: Following oral administration, D-psicose easily moved to blood. The maximum blood concentration (48.5±15.6 μg/g) was observed at 1 hour. Excretion to urine was 20% within 1 hour and 33% within 2 hours. Accumulation to organs was detected only in the liver. Following intravenous administration, blood concentration was decreased with the half-life=57 minutes, and the excretion to urine was up to almost 50% within 1 hour. Similarly to the results obtained with oral administration, accumulation to organs was detected only in the liver. Seven days after the single-dose oral administration, the remaining amounts in the whole body were less than 1%. Autoradiography of mice showed results similar to those in rats. High signals of (14)C-labeled D-psicose were observed in liver, kidney, and bladder. Interestingly, no accumulation of D-psicose was observed in the brain. CONCLUSION: D-psicose was absorbed well after oral administration and eliminated rapidly after both oral and intravenous administrations, with short duration of action. The study provides valuable pharmacokinetic data for further drug development of D-psicose. Because the findings were mainly based on animal study, it is necessary to implement human trials to study the metabolism pathway, which would give an important guide for human intake and food application of D-psicose. Dove Medical Press 2014-10-17 /pmc/articles/PMC4207542/ /pubmed/25378908 http://dx.doi.org/10.2147/DDDT.S60247 Text en © 2014 Tsukamoto et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Tsukamoto, Ikuko Hossain, Akram Yamaguchi, Fuminori Hirata, Yuko Dong, Youyi Kamitori, Kazuyo Sui, Li Nonaka, Machiko Ueno, Masaki Nishimoto, Kazuyuki Suda, Hirofumi Morimoto, Kenji Shimonishi, Tsuyoshi Saito, Madoka Song, Tao Konishi, Ryoji Tokuda, Masaaki Intestinal absorption, organ distribution, and urinary excretion of the rare sugar D-psicose |
title | Intestinal absorption, organ distribution, and urinary excretion of the rare sugar D-psicose |
title_full | Intestinal absorption, organ distribution, and urinary excretion of the rare sugar D-psicose |
title_fullStr | Intestinal absorption, organ distribution, and urinary excretion of the rare sugar D-psicose |
title_full_unstemmed | Intestinal absorption, organ distribution, and urinary excretion of the rare sugar D-psicose |
title_short | Intestinal absorption, organ distribution, and urinary excretion of the rare sugar D-psicose |
title_sort | intestinal absorption, organ distribution, and urinary excretion of the rare sugar d-psicose |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207542/ https://www.ncbi.nlm.nih.gov/pubmed/25378908 http://dx.doi.org/10.2147/DDDT.S60247 |
work_keys_str_mv | AT tsukamotoikuko intestinalabsorptionorgandistributionandurinaryexcretionoftheraresugardpsicose AT hossainakram intestinalabsorptionorgandistributionandurinaryexcretionoftheraresugardpsicose AT yamaguchifuminori intestinalabsorptionorgandistributionandurinaryexcretionoftheraresugardpsicose AT hiratayuko intestinalabsorptionorgandistributionandurinaryexcretionoftheraresugardpsicose AT dongyouyi intestinalabsorptionorgandistributionandurinaryexcretionoftheraresugardpsicose AT kamitorikazuyo intestinalabsorptionorgandistributionandurinaryexcretionoftheraresugardpsicose AT suili intestinalabsorptionorgandistributionandurinaryexcretionoftheraresugardpsicose AT nonakamachiko intestinalabsorptionorgandistributionandurinaryexcretionoftheraresugardpsicose AT uenomasaki intestinalabsorptionorgandistributionandurinaryexcretionoftheraresugardpsicose AT nishimotokazuyuki intestinalabsorptionorgandistributionandurinaryexcretionoftheraresugardpsicose AT sudahirofumi intestinalabsorptionorgandistributionandurinaryexcretionoftheraresugardpsicose AT morimotokenji intestinalabsorptionorgandistributionandurinaryexcretionoftheraresugardpsicose AT shimonishitsuyoshi intestinalabsorptionorgandistributionandurinaryexcretionoftheraresugardpsicose AT saitomadoka intestinalabsorptionorgandistributionandurinaryexcretionoftheraresugardpsicose AT songtao intestinalabsorptionorgandistributionandurinaryexcretionoftheraresugardpsicose AT konishiryoji intestinalabsorptionorgandistributionandurinaryexcretionoftheraresugardpsicose AT tokudamasaaki intestinalabsorptionorgandistributionandurinaryexcretionoftheraresugardpsicose |